Global Clinical Trial Management System Market Size, Share, Growth, Trends, Revenue, Consumption, Company Analysis and Forecast 2020-2027

CHAPTER 1. Preface
1.1.Report Scope and Market Segmentation
1.2.Research Highlights
1.3.Assumptions and Acronyms Used

CHAPTER 2. Research Methodology

CHAPTER 3. Executive Summary : Global Clinical Trial Management System Market

CHAPTER 4. Market Overview
4.1. Introduction
4.1.1. Clinical Trial Management System Definition
4.1.2. Key Industry Evolutions/ Developments
4.2. Overview: Global Clinical Trial Management System (CTSM) Market
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.5. Porter’s Five Force Analysis
4.6. Product Pipeline
4.7. Standards for data management in clinical trial study

5. Global Clinical Trial Management System (CTMS) Market Analysis, by Mode of Delivery
5.1. Introduction & Definition
5.2. Key Findings
5.3. Market Value Forecast, by Mode of Delivery , 2015–2025
5.3.1. On-premise
5.3.2. Web-based
5.3.3. Cloud-based
5.4. Market Attractiveness, by Mode of Delivery

6. Global Clinical Trial Management System (CTMS) Market Analysis, by Component
6.1. Introduction & Definition
6.2. Key Findings
6.3. Market Value Forecast, by Component, 2015–2025
6.3.1. Software
6.3.2. Hardware
6.3.3. Services
6.4. Market Attractiveness, by Components

7. Global Clinical Trial Management System (CTMS) Market Analysis, by Type
7.1. Introduction & Definition
7.2. Key Findings
7.3. Market Value Forecast, by Type, 2015–2025
7.3.1. Enterprise-based
7.3.2. Site-based
7.4. Market Attractiveness, by Type

8. Global Clinical Trial Management System (CTMS) Market Analysis, by End-user
8.1. Introduction & Definition
8.2. Key Findings
8.3. Market Value Forecast, by End-user, 2015–2025
8.3.1. Pharmaceutical Industries
8.3.2. Contract Research Organizations
8.3.3. Healthcare Providers
8.4. Market Attractiveness, by End-user

9. Global Clinical Trial Management System (CTMS) Market Analysis, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia
9.2.4. Rest of the World
9.3. Market Attractiveness by Region

10. North America Clinical Trial Management System Analysis and Forecast
10.1. Key Findings
10.2. North America Clinical Trial Management System (CTMS) Market Overview
10.3. Market Value Share, by Country/Sub-regions
10.3.1. U.S.
10.3.2. Canada
10.4. Market Value Share, by Mode of Delivery
10.4.1. Cloud-bases
10.4.2. Web-based
10.4.3. On-premise
10.5. Market Value Share, by Component
10.5.1. Software
10.5.2. Hardware
10.5.3. Services
10.6. Market Value Share, by Type
10.6.1. Enterprise-based
10.6.2. Site-based
10.7. Market Value Share, by End-user
10.7.1. Pharmaceutical Industries
10.7.2. Contract Research Organizations
10.7.3. Healthcare Providers
10.8. Market Attractiveness Analysis
10.8.1. By Country/Sub-region
10.8.2. By Mode of Delivery
10.8.3. By Component
10.8.4. By Type
10.8.5. By End-user

11. Europe Clinical Trial Management System Analysis and Forecast
11.1. Key Findings
11.2. Europe Clinical Trial Management System (CTMS) Market Overview
11.3. Market Value Share, by Country/Sub-regions
11.3.1. U.K.
11.3.2. France
11.3.3. Germany
11.3.4. Russia
11.3.5. Poland
11.3.6. Rest of Europe
11.4. Market Value Share, by Mode of Delivery
11.4.1. Cloud-based
11.4.2. Web-based
11.4.3. On-premise
11.5. Market Value Share, by Component
11.5.1. Software
11.5.2. Hardware
11.5.3. Services
11.6. Market Value Share, by Type
11.6.1. Enterprise-based
11.6.2. Site-based
11.7. Market Value Share, by End-user
11.7.1. Pharmaceutical Industries
11.7.2. Contract Research Organizations
11.7.3. Healthcare Providers
11.8. Market Attractiveness Analysis
11.8.1. By Country/Sub-region
11.8.2. By Mode of Delivery
11.8.3. By Component
11.8.4. By Type
11.8.5. By End-user

12. Asia Clinical Trial Management System Analysis and Forecast
12.1. Key Findings
12.2. Asia Clinical Trial Management System (CTMS) Market Overview
12.3. Market Value Share, by Country/Sub-regions
12.3.1. China
12.3.2. South Korea
12.3.3. Taiwan
12.3.4. India
12.3.5. Rest of Asia
12.4. Market Value Share, by Mode of Delivery
12.4.1. Cloud-based
12.4.2. Web-based
12.4.3. On-premise
12.5. Market Value Share, by Component
12.5.1. Software
12.5.2. Hardware
12.5.3. Services
12.6. Market Value Share By Type
12.6.1. Enterprise-based
12.6.2. Site-based
12.7. Market Value Share By End-user
12.7.1. Pharmaceutical Industries
12.7.2. Contract Research Organizations
12.7.3. Healthcare Providers
12.8. Market Attractiveness Analysis
12.8.1. By Country/Sub-region
12.8.2. By Mode of Delivery
12.8.3. By Component
12.8.4. By Type
12.8.5. By End-user

13. Rest of World (ROW) Clinical Trial Management System Market Analysis and Forecast
13.1. Key Findings
13.2. ROW Clinical Trial Management System (CTMS) Market Overview
13.3. Market Value Share By Mode of Delivery
13.3.1. Cloud-based
13.3.2. Web-based
13.3.3. On-premise
13.4. Market Value Share By Component
13.4.1. Software
13.4.2. Hardware
13.4.3. Services
13.5. Market Value Share By Type
13.5.1. Enterprise-based
13.5.2. Site-based
13.6. Market Value Share By End-user
13.6.1. Pharmaceutical Industries
13.6.2. Contract Research Organizations
13.6.3. Healthcare Providers
13.7. Market Attractiveness Analysis
13.7.1. By Mode of Delivery
13.7.2. By Component
13.7.3. By Type
13.7.4. By End-user

14. Competition Landscape
14.1.Market Player – Competition Matrix (By Tier and Size of companies)
14.2.Market Share Analysis By Company (2016)
14.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.3.1. Oracle
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Medidata
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. PAREXEL International Corporation
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. International Business Machines Corporation
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Cinven
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. MedNet Solutions, Inc
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Microsoft
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Apple Inc
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Bio-Optronics, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Cognizant Technology Solutions Corporation
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. DSG, Inc.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Financial Overview
14.3.11.3. Product Portfolio
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Forte Research Systems, Inc.
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Financial Overview
14.3.12.3. Product Portfolio
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Veeva Systems
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Financial Overview
14.3.13.3. Product Portfolio
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. DATATRAK Int
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Financial Overview
14.3.14.3. Product Portfolio
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview